相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic Levels of the Hydroxmethylglutaryl-Coenzyme A Reductase Inhibitor Lovastatin Activate Ras Signaling via Phospholipase D2
Kwang-jin Cho et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Angiotensin II Type 1 Receptor-Dependent Oxidative Stress Mediates Endothelial Dysfunction in Type 2 Diabetic Mice
Wing Tak Wong et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: Fluvastatin vs. rosuvastatin
Atsuko Tomizawa et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Endothelial Dysfunction: The Common Consequence in Diabetes and Hypertension
Wing Tak Wong et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling
Ling Gao et al.
CARDIOVASCULAR RESEARCH (2009)
Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase
Yiqun Wang et al.
CARDIOVASCULAR RESEARCH (2009)
Importance of Rac1 Signaling Pathway Inhibition in the Pleiotropic Effects of HMG-CoA Reductase Inhibitors
Mamunur Rashid et al.
CIRCULATION JOURNAL (2009)
Redox control of endothelial function and dysfunction: Molecular mechanisms and therapeutic opportunities
Shane R. Thomas et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Effect of rosuvastatin on capillary filtration of albumin and blood pressure in rats with streptozotocin-induced diabetes
Karima Tarhzaoui et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Exercise restores endothelial function independently of weight loss or hyperglycaemic status in db/db mice
F. Moien-Afshari et al.
DIABETOLOGIA (2008)
Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment
Adam Whaley-Connell et al.
HYPERTENSION (2008)
Participation of K+ channels in the endothelium-dependent and endothelium-independent components of the relaxant effect of rosuvastatin in rat aortic rings
Jorge Lopez et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2008)
The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose
Ludovica Piconi et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2008)
Rosuvastatin increases vascular endothelial PPAR gamma expression and corrects blood pressure variability in obese dyslipidaemic mice
Fanny Desjardins et al.
EUROPEAN HEART JOURNAL (2008)
The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation
Ramanna Merla et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
HMG-CoA reductase inhibitors decrease angiotensin-II-induced vascular fibrosis -: Role of RhoA/ROCK and MAPK pathways
Monica Ruperez et al.
HYPERTENSION (2007)
Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice
M. Fujii et al.
KIDNEY INTERNATIONAL (2007)
Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus
Andreas Schaefer et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Antioxidant and antiplatelet effects of rosuvastatin in a hamster model of prediabetes
Shane Miersch et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice
Jiu-Chang Zhong et al.
CARDIOVASCULAR RESEARCH (2007)
Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production
B Erdös et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH)
E ter Avest et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Rosuvastatin attenuates monocyte-endothelial cell interactions and vascular free radical production in hypercholesterolemic mice
W Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney - Reversal by angiotensin II type 1 receptor blockade
ZG Xu et al.
CIRCULATION (2005)
Simvastatin induces heme oxygenase-1 - A novel mechanism of vessel protection
TS Lee et al.
CIRCULATION (2004)
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy
D de Zeeuw et al.
CIRCULATION (2004)
Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose - Results from the LIPID trial
A Keech et al.
DIABETES CARE (2003)
Oxidative stress in the pathogenesis of thoracic aortic aneurysm: Protective role of statin and angiotensin II type 1 receptor blocker
J Ejiri et al.
CARDIOVASCULAR RESEARCH (2003)
Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice - Relationship to cholesterol biosynthesis pathway inhibition and lipid lowering
MR Nangle et al.
DIABETES (2003)
Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts
K Ohnaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species
S Wassmann et al.
HYPERTENSION (2001)
Behavioral science research in diabetes - Lifestyle changes related to obesity, eating behavior, and physical activity
RR Wing et al.
DIABETES CARE (2001)
Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering
SH Wilson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Endothelial dysfunction in diabetes
AS De Vriese et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
